ASCO Education Podcast show

ASCO Education Podcast

Summary: The ASCO Education Podcast is an educational series focused on helping learners identify knowledge gaps and stay up-to-date with the latest in new drug developments, cancer treatments and patient care approaches. The purpose of this podcast is to educate and to inform. This podcast is provided on the understanding that it does not constitute medical or other professional advice or services. It is no substitute for professional care by a doctor or other qualified medical professional and is not intended for use in the diagnosis or treatment of individual conditions. Guests who speak in this podcast express their own opinions, experience and conclusions. Neither American Society of Clinical Oncology nor any of its affiliates endorses, supports or opposes any particular treatment option or other matter discussed in this podcast. The mention of any product, service, organization, activity or therapy on the Podcast should not be construed as an ASCO endorsement.

Podcasts:

 ASCO Guidelines: Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer PCO | File Type: audio/mpeg | Duration: 14:42

ASCO Guidelines: Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer PCO

 ASCO Guidelines: Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer Guideline | File Type: audio/mpeg | Duration: 13:20

ASCO Guidelines: Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer Guideline

 ASCO Guidelines: Management of Cancer-associated Anemia with Erythropoiesis-Stimulating Agents Guideline | File Type: audio/mpeg | Duration: 09:34

ASCO Guidelines: Management of Cancer-associated Anemia with Erythropoiesis-Stimulating Agents Guideline

 Annual Meeting 2019 - EGFR Inhibitors | File Type: audio/mpeg | Duration: 09:38

Annual Meeting 2019 - EGFR Inhibitors

 Annual Meeting 2019 - Hepatocellular Carcinoma | File Type: audio/mpeg | Duration: 10:38

Annual Meeting 2019 - Hepatocellular Carcinoma

 Annual Meeting 2019 - PD1 Inhibitor Resistance in PDL1 Overexpressed Tumor | File Type: audio/mpeg | Duration: 08:49

Annual Meeting 2019 - PD1 Inhibitor Resistance in PDL1 Overexpressed Tumor

 Annual Meeting 2019 - Managing Burnout in Oncology | File Type: audio/mpeg | Duration: 06:22

Annual Meeting 2019 - Managing Burnout in Oncology

 Annual Meeting 2019 - Models of Genetic Counseling and Testing in Community Practices | File Type: audio/mpeg | Duration: 11:42

Annual Meeting 2019 - Models of Genetic Counseling and Testing in Community Practices

 Annual Meeting 2019 - Beyond Anti-PD-1/PD-L1 Therapy in Urothelial Cancer | File Type: audio/mpeg | Duration: 11:30

Annual Meeting 2019 - Beyond Anti-PD-1/PD-L1 Therapy in Urothelial Cancer

 Annual Meeting 2019 - Clinical Conundrums in the Management of Rectal Cancer | File Type: audio/mpeg | Duration: 12:31

Annual Meeting 2019 - Clinical Conundrums in the Management of Rectal Cancer

 Annual Meeting 2019 - Integrating Biomarkers and Targeted Therapy into Colorectal Cancer Management | File Type: audio/mpeg | Duration: 14:03

Annual Meeting 2019 - Integrating Biomarkers and Targeted Therapy into Colorectal Cancer Management

 Annual Meeting 2019 - The Role of Adjuvant Radiotherapy in Management of Nodal Disease | File Type: audio/mpeg | Duration: 13:42

Annual Meeting 2019 - The Role of Adjuvant Radiotherapy in Management of Nodal Disease

 Annual Meeting 2019 - Disparities in Prostate Care | File Type: audio/mpeg | Duration: 06:50

Annual Meeting 2019 - Disparities in Prostate Care

 Annual Meeting 2019 - The Stage IV Melanoma: What Biomarkers and Treatments Are Appropriate in the Frontline Setting? | File Type: audio/mpeg | Duration: 09:49

Annual Meeting 2019 - The Stage IV Melanoma: What Biomarkers and Treatments Are Appropriate in the Frontline Setting?

 Annual Meeting 2019 - Sustainable Oncology Research Programs | File Type: audio/mpeg | Duration: 07:20

Annual Meeting 2019 - Sustainable Oncology Research Programs

Comments

Login or signup comment.